Drug Information Association's Therapeutic Innovation & Regulatory Science (TIRS) journal
See the following -
TransCelerate BioPharma Inc. Publishes Risk-Based Monitoring Recommendations For Central Monitoring And Technology Considerations
Press Release |
TransCelerate BioPharma Inc. |
September 17, 2014
TransCelerate BioPharma Inc. ("TransCelerate") announced today the publication of its two most recent manuscripts on risk-based site monitoring ("Risk-Based Monitoring" or "RBM"), developed jointly by its 19 member companies. Both manuscripts have been accepted and published through the Drug Information Association's Therapeutic Innovation & Regulatory Science journal...
- Login to post comments